About
Minimally-invasive treatment for keratoconus
Areas of Focus
Categories
Drug Delivery DeviceSmall Molecule PharmaceuticalBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
800
By Phase
PHASE3: 2
By Status
ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06100952Lead Sponsor
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
PHASE3Active, not recruiting
400 participants
Started: Nov 1, 2023 · Completed: Nov 30, 2025
NCT06100939Lead Sponsor
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
PHASE3Active, not recruiting
400 participants
Started: Oct 30, 2023 · Completed: Oct 31, 2025
Locations (1)
Headquarters
Burlington, MA, United States
Map
Loading map...